Literature DB >> 19799840

Status of natural infection with Japanese encephalitis virus in Japan: prevalence of antibodies to the nonstructural 1 protein among humans and horses.

Eiji Konishi1.   

Abstract

The literature on natural infections with Japanese encephalitis virus in Japan and subclinical:clinical infection rates was summarized. To detect natural infections, conventional serologic methods were used in the past, while nonstructural 1 protein-based methods have been used recently. Annual infection rates in humans and horses indicated the status of natural virus activity in Japan.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19799840     DOI: 10.1016/j.vaccine.2009.09.052

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Comparable Accuracies of Nonstructural Protein 1- and Envelope Protein-Based Enzyme-Linked Immunosorbent Assays in Detecting Anti-Dengue Immunoglobulin G Antibodies.

Authors:  Jedhan Ucat Galula; Gielenny M Salem; Raul V Destura; Roland Remenyi; Day-Yu Chao
Journal:  Diagnostics (Basel)       Date:  2021-04-21

2.  Change in Dengue and Japanese Encephalitis Seroprevalence Rates in Sri Lanka.

Authors:  Chandima Jeewandara; Laksiri Gomes; S A Paranavitane; Mihiri Tantirimudalige; Sumedha Sandaruwan Panapitiya; Amitha Jayewardene; Samitha Fernando; R H Fernando; Shamini Prathapan; Graham S Ogg; Gathsaurie Neelika Malavige
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

3.  Investigation of dengue and Japanese encephalitis virus transmission in Hanam, Viet Nam.

Authors:  Annette Fox; Stephen Whitehead; Katherine L Anders; Le Nguyen Minh Hoa; Le Quynh Mai; Pham Quang Thai; Nguyen Thu Yen; Tran Nhu Duong; Dang Dinh Thoang; Jeremy Farrar; Heiman Wertheim; Cameron Simmons; Nguyen Tran Hien; Peter Horby
Journal:  Am J Trop Med Hyg       Date:  2014-03-10       Impact factor: 2.345

Review 4.  Epidemiology of Japanese encephalitis: past, present, and future prospects.

Authors:  Huanyu Wang; Guodong Liang
Journal:  Ther Clin Risk Manag       Date:  2015-03-19       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.